DENTSPLY SIRONA(US:XRAY) Benzinga·2025-05-08 17:31Core Insights - Dentsply Sirona Inc. experienced a significant stock surge of approximately 15%, marking its largest single-day increase since 2019, following the release of earnings that exceeded market expectations [1] - The company reported adjusted earnings per share of 43 cents for Q1 2025, surpassing the consensus estimate of 30 cents [1] - Net sales for the first quarter reached $879 million, exceeding the consensus of $854.75 million [1] Financial Performance - First quarter net sales decreased by 7.7% year-over-year, with organic sales declining by 4.4% compared to Q1 2024 [2] - Foreign currency fluctuations negatively impacted net sales by approximately $30 million in Q1 2025 [2] - Adjusted EBITDA increased by 4.2% to $168 million, with the EBITDA margin expanding from 16.8% to 19% [4] Strategic Outlook - The company maintains its guidance for adjusted earnings per share between $1.80 and $2.00, compared to the consensus of $1.82, considering foreign exchange changes and current tariffs [5] - Dentsply Sirona raised its fiscal 2025 sales guidance from a range of $3.50 billion-$3.60 billion to $3.60 billion-$3.70 billion, against a consensus of $3.57 billion [6] - Organic sales are projected to decline by 2.0% to 4.0%, which includes a 2% impact from Byte sales [6] Market Position - Analyst commentary suggests that despite the noise in the profit and loss statement, Dentsply Sirona shares are trading at a material discount to peers, with a valuation of 7 times the projected 2026 EPS [7] - The continued adoption of digital offerings is viewed positively, positioning Dentsply as a potential digital hub for accounts [7]